UnitedHealth Group Inc. (NYSE:UNH) 

Current assets and adjusted current assets both demonstrate a consistent upward trend over the five-year period from 2021 to 2025. The magnitude of the increase in adjusted current assets appears to consistently exceed that of reported current assets, suggesting the adjustments are contributing to a more substantial growth in the reported asset base.

Overall Growth

Reported current assets increased from US$61,758 million in 2021 to US$90,582 million in 2025, representing a cumulative growth of approximately 46.7%. Adjusted current assets experienced a more pronounced increase, growing from US$63,705 million in 2021 to US$95,553 million in 2025, a cumulative growth of roughly 50.0%.

Year-over-Year Changes

The year-over-year growth in both current assets and adjusted current assets was generally positive throughout the period. The largest absolute increase in reported current assets occurred between 2022 and 2023 (US$9,368 million), while the largest absolute increase in adjusted current assets also occurred between 2022 and 2023 (US$10,142 million). Growth rates appear to decelerate slightly from 2024 to 2025 for both metrics, although they remain positive.

Adjustment Impact

The difference between current assets and adjusted current assets remains relatively stable over the period, consistently around US$1,947 million to US$2,200 million. This suggests a systematic and consistent application of the adjustments to current assets. The adjustments consistently increase the reported value of current assets, indicating they represent items not initially included in the standard current asset classification.

The consistent growth in both reported and adjusted current assets suggests a strengthening financial position. The consistent application of adjustments indicates a deliberate approach to financial reporting and potentially reflects the inclusion of items that provide a more comprehensive view of the company’s short-term liquidity.

Total assets and adjusted total assets both demonstrate a consistent upward trend over the five-year period from 2021 to 2025. However, the adjusted total assets consistently exceed reported total assets throughout the observed timeframe, indicating the presence of adjustments being made to the company’s asset valuation.

Overall Growth

Reported total assets increased from US$212,206 million in 2021 to US$309,581 million in 2025, representing a growth of approximately 45.9%. Adjusted total assets experienced a similar growth pattern, rising from US$214,153 million in 2021 to US$314,552 million in 2025, a growth of roughly 46.9%.

Year-over-Year Changes

The year-over-year growth in both total assets and adjusted total assets generally decelerated over the period. The largest percentage increase in total assets occurred between 2021 and 2022 (15.7%), while the smallest occurred between 2024 and 2025 (3.5%). A similar pattern is observed for adjusted total assets.

Adjustment Magnitude

The difference between adjusted total assets and total assets remained relatively stable in absolute terms, ranging from approximately US$1,947 million to US$4,971 million. This suggests that the nature and scale of the adjustments are consistent over the period. The difference as a percentage of total assets decreased slightly from 1.0% in 2021 to 1.6% in 2025.

The consistent positive adjustments to total assets suggest the company is recognizing value not immediately reflected in its initially reported asset base. Further investigation into the specific nature of these adjustments would be necessary to understand their underlying drivers and potential impact on the company’s financial position.

Current liabilities exhibited a consistent upward trend over the five-year period, increasing from 78,292 US$ millions in 2021 to 114,897 US$ millions in 2025. Adjusted current liabilities mirrored this pattern, also demonstrating growth throughout the period, albeit at a slightly lower magnitude. The difference between reported and adjusted current liabilities appears to be relatively stable over time.

Overall Trend

Both current liabilities and adjusted current liabilities increased annually. The growth rate appears to have moderated slightly in the later years of the period, particularly when observing the difference between 2023-2024 and 2024-2025.

Magnitude of Change

The largest absolute increase in current liabilities occurred between 2021 and 2022, with an increase of 10,945 US$ millions. The largest absolute increase in adjusted current liabilities also occurred between 2021 and 2022, with an increase of 10,441 US$ millions. The increase from 2024 to 2025 was smaller for both metrics, at 11,128 US$ millions for current liabilities and 10,032 US$ millions for adjusted current liabilities.

Difference Between Reported and Adjusted Values

The difference between current liabilities and adjusted current liabilities was 2,571 US$ millions in 2021. This difference increased to 3,313 US$ millions in 2022, 3,355 US$ millions in 2023, 3,317 US$ millions in 2024, and 3,413 US$ millions in 2025. The relatively consistent difference suggests a systematic adjustment being applied each year.

The consistent growth in both reported and adjusted current liabilities warrants further investigation to understand the underlying drivers. The stable difference between the two figures suggests the adjustments are related to recurring items, and a detailed review of the nature of these adjustments would be beneficial.

Total liabilities and adjusted total liabilities both demonstrate a consistent upward trend over the five-year period from 2021 to 2025. However, the magnitude of increase differs between the two measures, indicating a systematic adjustment being applied to reported liabilities.

Overall Growth

Total liabilities increased from US$135,727 million in 2021 to US$207,883 million in 2025, representing a cumulative growth of approximately 53.1%. Adjusted total liabilities grew from US$129,891 million to US$202,049 million over the same period, a cumulative increase of roughly 55.7%.

Year-over-Year Changes

The year-over-year increases in total liabilities were: US$23,631 million (2022), US$15,443 million (2023), US$20,886 million (2024), and US$10,196 million (2025). The corresponding increases for adjusted total liabilities were: US$23,623 million (2022), US$14,911 million (2023), US$19,999 million (2024), and US$14,200 million (2025). The adjusted figures consistently show slightly lower absolute increases than the reported total liabilities.

Adjustment Impact

The difference between total liabilities and adjusted total liabilities varied annually. In 2021, the adjustment reduced reported liabilities by US$5,836 million. This difference widened to US$5,844 million in 2022, then to US$6,376 million in 2023. In 2024, the adjustment amounted to US$6,937 million, and in 2025, it reached US$5,834 million. The consistent application of this adjustment suggests a recurring item impacting the reported liability position.

The growth rates of both liability measures remained relatively stable throughout the period, although the increase in 2025 was notably lower than in 2022, 2023, and 2024. The persistent difference between the two liability figures warrants further investigation to understand the nature and rationale behind the adjustments being made.

Shareholders’ equity attributable to UnitedHealth Group demonstrated a consistent upward trajectory between 2021 and 2025. However, the rate of growth varied over the period. Adjusted total equity exhibited a similar pattern, consistently increasing, but with a more pronounced growth rate than shareholders’ equity attributable to the company.

Shareholders’ Equity Trend

Shareholders’ equity attributable to UnitedHealth Group increased from US$71,760 million in 2021 to US$94,110 million in 2025, representing a cumulative growth of approximately 31.1%. The largest year-over-year increase occurred between 2022 and 2023, with an addition of US$10,984 million. Growth slowed in subsequent years, with increases of US$3,892 million between 2023 and 2024, and US$552 million between 2024 and 2025.

Adjusted Total Equity Trend

Adjusted total equity experienced more substantial growth, rising from US$84,262 million in 2021 to US$112,503 million in 2025, a cumulative increase of approximately 33.5%. Similar to shareholders’ equity, the most significant year-over-year growth was observed between 2022 and 2023, adding US$13,737 million. The rate of increase decelerated in 2024 (US$4,998 million) and experienced a slight decrease in 2025 (US$874 million).

Relationship Between Equity Measures

The difference between adjusted total equity and shareholders’ equity attributable to UnitedHealth Group remained relatively stable over the observed period, fluctuating between approximately US$12,500 million and US$13,800 million. This suggests that the adjustments made to total equity consistently impacted the overall equity position by a similar magnitude each year. The gap widened slightly in 2025.

The deceleration in growth for both equity measures towards the end of the period warrants further investigation. The slight decrease in adjusted total equity in 2025 is also notable and could indicate a shift in the composition of equity or the impact of specific accounting adjustments.

Over the five-year period ending December 31, 2025, both reported and adjusted financial metrics demonstrate consistent growth. Total reported debt increased from US$46,003 million in 2021 to US$78,389 million in 2025, while shareholders’ equity attributable to UnitedHealth Group rose from US$71,760 million to US$94,110 million over the same timeframe. Correspondingly, total reported capital experienced an increase, moving from US$117,763 million to US$172,499 million. The adjusted figures show similar upward trajectories, with adjusted total debt increasing from US$50,276 million to US$83,004 million and adjusted total equity growing from US$84,262 million to US$112,503 million. Adjusted total capital increased from US$134,538 million to US$195,507 million.

Debt Trends

Reported total debt exhibited a more rapid increase between 2021 and 2024, growing by approximately 67%, before slowing to a 1.9% increase between 2024 and 2025. Adjusted total debt followed a similar pattern, with a substantial increase through 2024 and a more moderate increase in 2025. The difference between reported and adjusted debt figures widened over the period, suggesting increasing adjustments are being made to the initially reported debt values.

Equity Trends

Shareholders’ equity attributable to UnitedHealth Group demonstrated steady growth throughout the period, with a cumulative increase of approximately 31%. Adjusted total equity also showed consistent growth, with a cumulative increase of approximately 33%. The adjusted equity values consistently exceeded the reported equity values, indicating that adjustments to equity are increasing the reported equity position.

Capital Structure Changes

Total reported capital increased by approximately 46% over the five years. Adjusted total capital experienced a similar growth rate, increasing by approximately 45%. The gap between reported and adjusted capital widened over the period, mirroring the trend observed in debt and equity. The adjustments to both debt and equity contribute to a higher adjusted capital base compared to the reported capital base.

Adjustment Impact

The difference between reported and adjusted figures for debt, equity, and capital increased each year. This suggests a growing impact from the adjustments being made to the financial statements. Further investigation into the nature of these adjustments would be necessary to understand their underlying causes and implications.

In summary, the financial position, as reflected by both reported and adjusted figures, strengthened over the period. However, the increasing magnitude of adjustments to the capitalization structure warrants further scrutiny to determine the specific items being adjusted and their potential impact on the overall financial health of the organization.

Revenues reported from customers demonstrate a consistent upward trajectory over the five-year period. Simultaneously, adjusted revenues from customers also exhibit an increasing trend. However, a close examination reveals a slight divergence between the two revenue streams.

Overall Revenue Growth

Customer revenues increased from US$285,273 million in 2021 to US$443,647 million in 2025, representing a substantial overall growth. The compound annual growth rate (CAGR) for customer revenues over this period is approximately 12.8%.

Adjusted Revenue Growth

Adjusted customer revenues also increased, moving from US$285,002 million in 2021 to US$443,743 million in 2025. The CAGR for adjusted customer revenues is approximately 12.8%.

Difference Between Revenue Streams

The difference between reported customer revenues and adjusted customer revenues is relatively small throughout the period. In 2021, the difference was US$271 million. This difference widened slightly to US$389 million in 2022, then narrowed to US$280 million in 2023. It remained minimal in 2024 at US$38 million, and increased again to US$96 million in 2025. This suggests that adjustments are generally minor, but the magnitude fluctuates year to year.

The consistency in the growth rates of both revenue streams indicates that the adjustments applied do not fundamentally alter the overall revenue performance. The small and variable difference between the two figures suggests that the adjustments relate to specific, potentially recurring, items that are not consistently material.

Year-over-Year Changes

The largest absolute increase in both revenue streams occurred between 2022 and 2023. The year-over-year growth rate decelerated slightly between 2023 and 2024, and again between 2024 and 2025, although growth remained positive.

Further investigation into the nature of the adjustments would be necessary to fully understand their impact and the reasons for the fluctuations in the difference between the two revenue figures.

Net earnings attributable to UnitedHealth Group common shareholders exhibited growth from 2021 to 2023, followed by declines in both 2024 and 2025. Adjusted net earnings demonstrate a similar pattern, though with differing magnitudes of change. A notable divergence between reported and adjusted earnings is apparent, particularly in 2023 and 2024.

Net Earnings Trend

Net earnings increased from US$17,285 million in 2021 to US$22,381 million in 2023, representing a compound annual growth rate of approximately 11.7%. However, net earnings decreased significantly to US$14,405 million in 2024 and further to US$12,056 million in 2025. This indicates a substantial reversal of the prior growth trend.

Adjusted Net Earnings Trend

Adjusted net earnings also increased from 2021 to 2023, moving from US$15,931 million to US$25,319 million, a compound annual growth rate of roughly 13.1%. Similar to net earnings, adjusted net earnings declined in 2024 to US$19,313 million and continued to decrease in 2025 to US$13,599 million. The rate of decline appears to be moderating in 2025 compared to 2024.

Relationship Between Reported and Adjusted Earnings

The difference between net earnings and adjusted net earnings was relatively small in 2021 and 2022. However, in 2023, adjusted net earnings exceeded reported net earnings by approximately US$2,998 million. This difference widened in 2024, with adjusted net earnings being US$4,908 million lower than reported net earnings. In 2025, the difference narrowed to US$1,543 million, with adjusted net earnings lower than reported net earnings. These variations suggest the presence of significant non-recurring or unusual items impacting reported earnings, which are being excluded in the adjusted figures.

The declines observed in both net and adjusted earnings in the later years warrant further investigation to determine the underlying causes. The increasing gap between reported and adjusted earnings highlights the importance of understanding the nature of the adjustments being made to arrive at the adjusted figures.